Global Bio-chem Technology Group Company Limited
0809.HK · HKSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.02 | -0.00 | -0.00 | 0.03 |
| FCF Yield | 8.03% | -9.98% | -6.78% | -45.36% |
| EV / EBITDA | 270.10 | 1.34 | -21.87 | 12.13 |
| Quality | ||||
| ROIC | -8.00% | -21.92% | -20.82% | -19.01% |
| Gross Margin | 10.93% | 3.18% | -2,072.02% | 6.48% |
| Cash Conversion Ratio | 0.10 | -0.01 | 0.06 | 1.16 |
| Growth | ||||
| Revenue 3-Year CAGR | 439.96% | 22.55% | -75.35% | 9,071,554.34% |
| Free Cash Flow Growth | 180.69% | -0.05% | 81.20% | -1,064.73% |
| Safety | ||||
| Net Debt / EBITDA | 213.94 | 1.14 | -18.91 | 10.72 |
| Interest Coverage | -0.43 | -0.42 | -0.39 | -0.47 |
| Efficiency | ||||
| Inventory Turnover | 8.67 | 8.97 | 1.56 | 8.58 |
| Cash Conversion Cycle | 115.63 | -102.20 | 6,955.79 | -353.58 |